Hyperimmunoglobulinemia D with periodic fever Advocacy Hub | UniteRare

At a Glance

Live from database

💊

2FDA treatments

💰

3Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Hyperimmunoglobulinemia D with periodic fever.

Financial Assistance

3 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance3

Tybost

Gilead

OpenContact for detailsApply ↗

Pentamidine Isethionate

Fresenius Kabi

OpenContact for details

Norvir

AbbVie

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

ILARIS

(canakinumab)Orphan drugstandard

Novartis Pharmaceuticals Corporation

12.1 Mechanism of Action Canakinumab is a human monoclonal anti-human IL-1β antibody of the IgG1/κ isotype. Canakinumab binds to human IL-1β and neutr...

FDA label ↗

Siklos

(hydroxycarbamide (hydroxyurea))Orphan drugstandard

Theravia Pharma

Antimetabolite [EPC]

12.1 Mechanism of Action The precise mechanism by which hydroxyurea produces its cytotoxic and cytoreductive effects is not known. However, various st...

FDA label ↗

View full treatment details on disease page →